O’Grady, M. A., Elkington, K. S., Robson, G., Achebe, I. Y., Williams, A. R., Cohall, A. T., Cohall, R., Christofferson, M., Garcia, A., Ramsey, K. S., Lincourt, P., & Tross, S. (2024). Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators. Substance Abuse Treatment, Prevention, and Policy, 19(1). https://doi.org/10.1186/s13011-024-00593-y

Paschen-Wolff, M. M., DeSousa, A., Paine, E. A., Hughes, T. L., & Campbell, A. N. C. (2024). Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance Abuse Treatment, Prevention, and Policy, 19(1). https://doi.org/10.1186/s13011-023-00581-8

Moody, R. L., Chen, Y.-T., Schneider, J. A., Knox, J., Timmins, L., Hanson, H., Koli, K., Durrell, M., Dehlin, J., Eavou, R., Martins, S. S., & Duncan, D. T. (2022). Polysubstance use in a community sample of Black cisgender sexual minority men and transgender women in Chicago during initial COVID-19 pandemic peak. Substance Abuse Treatment, Prevention, and Policy, 17(1). https://doi.org/10.1186/s13011-022-00433-x

Hirchak, K. A., Amiri, S., Kordas, G., Oluwoye, O., Lyons, A. J., Bajet, K., Hahn, J. A., McDonell, M. G., Campbell, A. N. C., & Venner, K. (2022). Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes. Substance Abuse Treatment, Prevention, and Policy, 17(1). https://doi.org/10.1186/s13011-022-00457-3

Papp, M. A., Leff, J. A., Murphy, S. M., Yang, A., Crane, H. M., Metsch, L. R., Del Rio, C., Feaster, D. J., Rich, J. D., Schackman, B. R., & McCollister, K. E. (2021). Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research. Substance Abuse Treatment, Prevention, and Policy, 16(1). https://doi.org/10.1186/s13011-021-00356-z